查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585981

C 反應蛋白檢測市場：按檢測類型、疾病領域、檢測範圍和最終用戶分類 - 2025-2030 年全球預測

C-Reactive Protein Testing Market by Assay Type (Chemiluminescence Immunoassay, ELISA, Immunoturbidimetric Assay), Disease Area (Cancer, Cardiovascular Diseases, Endometriosis), Detection Range, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年C反應蛋白檢測市場價值為15億美元，預計2024年將達到16.9億美元，複合年成長率為12.41%，到2030年將達到34.2億美元。

C反應蛋白（CRP）測試是用於評估體內發炎和感染疾病的重要診斷工具，也是心血管疾病、感染疾病和慢性發炎疾病等疾病的重要標誌。 CRP 檢測的重要性在於其在各種醫療保健環境中的應用，可幫助臨床醫生診斷和監測類風濕性關節炎、紅斑性狼瘡和敗血症等疾病。最終用途包括醫院、診斷實驗室、學術研究機構和居家醫療機構。慢性病盛行率的上升、預防保健需求的增加以及生物技術的進步是推動該市場成長的主要因素。技術進步，特別是在高靈敏度 CRP檢測法的進步，為提高診斷的準確性和速度提供了機會。向個人化醫療的轉變和對預防性醫療保健的日益重視為成長提供了進一步的途徑。然而，市場面臨設備高成本、監管複雜性以及發炎替代生物標記可用性等挑戰。此外，人們也擔心，由於標準化不足，CRP 測試結果會有所不同。為了利用商機，公司應專注於創新，例如開發具有成本效益的快速就地檢驗解決方案、標準化測試方法以及整合先進的資料分析以增強測試解釋。此外，提高對 CRP 測試在預防性醫療保健中的好處的認知和教育可能會提高採用率。全球和區域市場競爭日益加劇，維持市場相關性需要持續的研發和策略聯盟。最終，追求提高檢測靈敏度和特異性，以及提高全球意識和簡化供應鏈的努力，將有助於克服現有限制並實現潛在成長區域，特別是在開拓市場。

主要市場統計
基準年[2023] 15億美元
預測年份 [2024] 16.9億美元
預測年份 [2030] 34.2億美元
複合年成長率（%） 12.41%

市場動態：揭示快速發展的 C 反應蛋白測試市場的關鍵市場洞察

C反應蛋白檢測市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 需要測量各種健康狀況引起的發炎
    • 慢性病盛行率上升和老年人口增加
    • 改進 C 反應蛋白就地檢驗以安全減重抗生素劑量
  • 市場限制因素
    • C反應蛋白檢測的有效性和特異性問題
  • 市場機會
    • 傳統 CRP 測試的技術進步
    • CRP在犬胃腸道疾病的研究
  • 市場挑戰
    • 嚴格的檢驗技術和產品核准流程

波特五力：駕馭 C 反應蛋白檢測市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解 C 反應蛋白檢測市場的外部影響

外部宏觀環境因素在塑造 C 反應蛋白檢測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解 C 反應蛋白檢測市場的競爭格局

C反應蛋白檢測市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣 C 反應蛋白檢測市場供應商的績效評估

FPNV定位矩陣是評估C反應蛋白檢測市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了 C 反應蛋白檢測市場的成功之路

對於旨在加強其全球市場影響力的公司來說，對 C 反應蛋白檢測市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 需要測量各種健康狀況引起的發炎
      • 慢性病發生率上升和老年人口增加
      • 改善C反應蛋白的現場檢測，減少抗生素的安全使用
    • 抑制因素
      • 與 C 反應蛋白檢測的有效性和特異性相關的問題
    • 機會
      • 傳統 CRP 測試的技術進步
      • C反應蛋白在犬胃腸道疾病的研究
    • 任務
      • 嚴格的測試技術和產品核准流程
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 C 反應蛋白檢測市場（依檢測類型）

  • 化學冷光免疫檢測
    • 游離三碘甲狀腺素
    • 游離4碘甲狀腺素
    • 甲狀腺刺激素水平
  • 酵素連結免疫吸附試驗
    • 臨床
    • 非臨床
  • 免疫比濁法
  • 免疫檢測
    • 抗促甲狀腺刺激素受體自體抗體
    • 人類血清甲狀腺球蛋白自體抗體
    • 甲狀腺過氧化物酶自體抗體

第7章依疾病領域分類的C反應蛋白檢測市場

  • 癌症
  • 心血管疾病
  • 子宮內膜異位症
  • 發炎性腸道疾病
  • 狼瘡
  • 類風濕性關節炎

第8章 C 反應蛋白檢測市場（依檢測範圍）

  • 慢性CRP
  • 常規CRP
  • hs-CRP

第 9 章 C 反應蛋白測試市場：依最終用戶分類

  • 輔助生活醫療設施
  • 診所
  • 醫院
  • 研究所

第10章美洲C反應蛋白檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太C反應蛋白檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲/中東/非洲C反應蛋白檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Abcam PLC
  • Alere Inc.
  • BIOMERIEUX
  • BODITECH MED, Inc.
  • CTK Biotech Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Eurolyser Diagnostica GmbH
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Corporation
  • Getein Biotech, Inc.
  • HORIBA, Ltd.
  • Laboratory Corporation of America Holdings（LabCorp）
  • Lumiradx Healthcare Private Limited
  • Merck KGaA
  • Ortho Clinical Diagnostics
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • SD Biosensor, Inc.
  • Sekisui Diagnostics
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC
  • Zoetis Inc.
Product Code: MRR-A339DAEFABD5

The C-Reactive Protein Testing Market was valued at USD 1.50 billion in 2023, expected to reach USD 1.69 billion in 2024, and is projected to grow at a CAGR of 12.41%, to USD 3.42 billion by 2030.

C-Reactive Protein (CRP) Testing is a pivotal diagnostic tool used for assessing inflammation or infection in the body, an essential marker indicating conditions like cardiovascular diseases, infections, and chronic inflammatory diseases. The importance of CRP testing lies in its application across various healthcare settings, aiding clinicians in diagnosing and monitoring conditions such as rheumatoid arthritis, lupus, and sepsis, among others. The end-use scope spans hospitals, diagnostic laboratories, academic and research institutions, and home care settings. The rising prevalence of chronic diseases, increasing demand for preventive healthcare, and advances in biotechnology are key factors fueling the growth of this market. Technological advancements, particularly in high-sensitivity CRP assays, present opportunities to enhance diagnostic accuracy and speed. The shift towards personalized medicine and the growing emphasis on preventive healthcare offer additional growth avenues. However, the market faces challenges such as the high cost of equipment, regulatory complexities, and the availability of alternative biomarkers that can also indicate inflammation. Additionally, variability in CRP test results due to poor standardization remains a concern. To capitalize on opportunities, businesses should focus on innovations like developing cost-effective, rapid, point-of-care testing solutions, achieving standardization in assays, and integrating advanced data analytics to enhance test interpretations. Furthermore, expanding awareness and education regarding the benefits of CRP testing in preventive health can drive adoption rates. The market is competitive with numerous global and regional players, necessitating continuous research and development (R&D) and strategic partnerships to maintain market relevance. Ultimately, the pursuit of improving assay sensitivity and specificity, along with initiatives for global awareness and streamlined supply chains, will be crucial in overcoming existing limitations and tapping into potential growth regions, especially in emerging markets.

KEY MARKET STATISTICS
Base Year [2023] USD 1.50 billion
Estimated Year [2024] USD 1.69 billion
Forecast Year [2030] USD 3.42 billion
CAGR (%) 12.41%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving C-Reactive Protein Testing Market

The C-Reactive Protein Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Need to measure inflammation caused by a wide variety of health conditions
    • Rising incidence of chronic disorders and growing geriatric population
    • Improvements in C-reactive protein point-of-care testing for safely reducing antibiotic
  • Market Restraints
    • Issues associated with efficacy and specificity of C-Reactive protein testing
  • Market Opportunities
    • Technological advancements pertaining to conventional CRP tests
    • Research on C-reactive protein in gastrointestinal diseases of dogs
  • Market Challenges
    • Stringent approval processes for testing techniques and products

Porter's Five Forces: A Strategic Tool for Navigating the C-Reactive Protein Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the C-Reactive Protein Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the C-Reactive Protein Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the C-Reactive Protein Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the C-Reactive Protein Testing Market

A detailed market share analysis in the C-Reactive Protein Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the C-Reactive Protein Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the C-Reactive Protein Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the C-Reactive Protein Testing Market

A strategic analysis of the C-Reactive Protein Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the C-Reactive Protein Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Alere Inc., BIOMERIEUX, BODITECH MED, Inc., CTK Biotech Inc., Danaher Corporation, DiaSorin S.p.A., Eurolyser Diagnostica GmbH, F. Hoffmann-La Roche Ltd., Fujifilm Corporation, Getein Biotech, Inc., HORIBA, Ltd., Laboratory Corporation of America Holdings (LabCorp), Lumiradx Healthcare Private Limited, Merck KGaA, Ortho Clinical Diagnostics, Quest Diagnostics Incorporated, Randox Laboratories Ltd., SD Biosensor, Inc., Sekisui Diagnostics, Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Trinity Biotech PLC, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the C-Reactive Protein Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Assay Type, market is studied across Chemiluminescence Immunoassay, ELISA, Immunoturbidimetric Assay, and Radioimmunoassay. The Chemiluminescence Immunoassay is further studied across Free T3, Free T4, and Thyrotropin Levels. The ELISA is further studied across Clinical and Nonclinical. The Radioimmunoassay is further studied across Autoantibodies Against Thyrotropin Receptor, Human Serum Thyroglobulin Autoantibodies, and Thyroperoxidase Autoantibodies.
  • Based on Disease Area, market is studied across Cancer, Cardiovascular Diseases, Endometriosis, Inflammatory Bowel Disease, Lupus, and Rheumatoid Arthritis.
  • Based on Detection Range, market is studied across cCRP, Conventional CRP, and hs-CRP.
  • Based on End-User, market is studied across Assisted Living Healthcare Facilities, Clinics, Hospitals, and Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need to measure inflammation caused by a wide variety of health conditions
      • 5.1.1.2. Rising incidence of chronic disorders and growing geriatric population
      • 5.1.1.3. Improvements in C-reactive protein point-of-care testing for safely reducing antibiotic
    • 5.1.2. Restraints
      • 5.1.2.1. Issues associated with efficacy and specificity of C-Reactive protein testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements pertaining to conventional CRP tests
      • 5.1.3.2. Research on C-reactive protein in gastrointestinal diseases of dogs
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent approval processes for testing techniques and products
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. C-Reactive Protein Testing Market, by Assay Type

  • 6.1. Introduction
  • 6.2. Chemiluminescence Immunoassay
    • 6.2.1. Free T3
    • 6.2.2. Free T4
    • 6.2.3. Thyrotropin Levels
  • 6.3. ELISA
    • 6.3.1. Clinical
    • 6.3.2. Nonclinical
  • 6.4. Immunoturbidimetric Assay
  • 6.5. Radioimmunoassay
    • 6.5.1. Autoantibodies Against Thyrotropin Receptor
    • 6.5.2. Human Serum Thyroglobulin Autoantibodies
    • 6.5.3. Thyroperoxidase Autoantibodies

7. C-Reactive Protein Testing Market, by Disease Area

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Cardiovascular Diseases
  • 7.4. Endometriosis
  • 7.5. Inflammatory Bowel Disease
  • 7.6. Lupus
  • 7.7. Rheumatoid Arthritis

8. C-Reactive Protein Testing Market, by Detection Range

  • 8.1. Introduction
  • 8.2. cCRP
  • 8.3. Conventional CRP
  • 8.4. hs-CRP

9. C-Reactive Protein Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Assisted Living Healthcare Facilities
  • 9.3. Clinics
  • 9.4. Hospitals
  • 9.5. Laboratories

10. Americas C-Reactive Protein Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific C-Reactive Protein Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa C-Reactive Protein Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Abcam PLC
  • 3. Alere Inc.
  • 4. BIOMERIEUX
  • 5. BODITECH MED, Inc.
  • 6. CTK Biotech Inc.
  • 7. Danaher Corporation
  • 8. DiaSorin S.p.A.
  • 9. Eurolyser Diagnostica GmbH
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Fujifilm Corporation
  • 12. Getein Biotech, Inc.
  • 13. HORIBA, Ltd.
  • 14. Laboratory Corporation of America Holdings (LabCorp)
  • 15. Lumiradx Healthcare Private Limited
  • 16. Merck KGaA
  • 17. Ortho Clinical Diagnostics
  • 18. Quest Diagnostics Incorporated
  • 19. Randox Laboratories Ltd.
  • 20. SD Biosensor, Inc.
  • 21. Sekisui Diagnostics
  • 22. Siemens Healthineers AG
  • 23. Thermo Fisher Scientific, Inc.
  • 24. Trinity Biotech PLC
  • 25. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. C-REACTIVE PROTEIN TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. C-REACTIVE PROTEIN TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. C-REACTIVE PROTEIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. C-REACTIVE PROTEIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. C-REACTIVE PROTEIN TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. C-REACTIVE PROTEIN TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY FREE T3, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY FREE T4, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY THYROTROPIN LEVELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY NONCLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY IMMUNOTURBIDIMETRIC ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY AUTOANTIBODIES AGAINST THYROTROPIN RECEPTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HUMAN SERUM THYROGLOBULIN AUTOANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY THYROPEROXIDASE AUTOANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY LUPUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CCRP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CONVENTIONAL CRP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HS-CRP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSISTED LIVING HEALTHCARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 315. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES C-REACTIVE PROTEIN T